Summary
36 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- It has been profitable 6 years in a row.
What to watch
- Repaying its net debt would take 14.4 years of operating profit.
- Revenue fell by 3.8% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 9.6 HKD for 1 HKD of yearly profit.
Valuation in detailIs it growing?
It is shrinkingRevenue (HKD)
Diluted EPS (HKD)
Revenue fell by 23% a year over 5 years. Over the last 3 years it fell by 3.8% a year.
Growth in detailDoes it make money?
ReasonablyWhere 100 HKD of revenue goes
- Cost of sales 74 HKD
- Sales and administration 25 HKD
- Taxes and other -5.2 HKD
- Net profit 6.6 HKD
Net profit, industry median (Chemicals - Specialty) 5.9 HKD
Out of every 100 HKD of revenue, 6.6 HKD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 9.4 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 6.80%
- Paid out of profit
- 65%
- Raised in a row
- 1 year
You receive $0.02 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.